Skip to content
USAID: From The American People TB-DIAH: Tuberculosis Data, Impact Assessment and Communications Hub
  • Knowledge Hub
  • Data Hub
  • Home
  • About
    • Project Overview & Objectives
    • TB DIAH Team
  • Countries
    • Afghanistan
    • Bangladesh
    • Burma
    • Cambodia
    • DRC
    • Ethiopia
    • India
    • Indonesia
    • Kenya
    • Kyrgyz Republic
    • Malawi
    • Mozambique
    • Nigeria
    • Pakistan
    • Philippines
    • South Africa
    • Tajikistan
    • Tanzania
    • Uganda
    • Ukraine
    • Uzbekistan
    • Vietnam
    • Zambia
    • Zimbabwe
  • Tools
    • ARCAssessment of Data Collection, Reporting & Analysis Capacity
    • D2ACData-to-Action Continuum Toolkit
    • MESSAM&E and Surveillance Systems Assessment
    • PBMEFPerformance-Based M&E Framework
    • QTSAQuality of Tuberculosis Services Assessment
    • STEPSurveillance and TB M&E Strengthening Plan
  • Resources
    • Capacity Strengthening
    • Center of Excellence
    • e-Learning Courses
    • NTP Website Activity
    • Resource Library
  • News
    • TB DIAH Digest
    • Social Media
    • 2023 Union Conference
    • Webinars

Resource Tag: DR-TB

Лекарственно-устойчивый туберкулез: интерпретация результатов быстрых молекулярных тестов

Лекарственно-устойчивый туберкулез: интерпретация результатов быстрых молекулярных тестов
Author(s): WHO
Filed under: clinical, Course, Diagnosis, Diagnostics, DR-TB, drug resistance, Drug susceptibility testing, Drug-resistant TB, DST, e-course, e-learning, GeneXpert, Guidance and Tools, learning, rapid, rapid diagnostics, rapid molecular test, rapid test, Russian, TB, Toolkit, Training, Tuberculosis, WHO, World Health Organization
Continue Reading

Drug-resistant tuberculosis: how to interpret rapid molecular test results

Drug-resistant tuberculosis: how to interpret rapid molecular test results
Author(s): WHO
Filed under: clinical, Course, Diagnosis, Diagnostics, DR-TB, drug resistance, Drug susceptibility testing, Drug-resistant TB, DST, e-course, e-learning, GeneXpert, Guidance and Tools, learning, rapid, rapid diagnostics, rapid molecular test, rapid test, TB, Toolkit, Training, Tuberculosis, WHO, World Health Organization
Continue Reading

Програмне та клінічне лікування пацієнтів із стійким до лікарських засобів туберкульозом

Програмне та клінічне лікування пацієнтів із стійким до лікарських засобів туберкульозом
Author(s): The Union
Year: 2022
Filed under: clinical, Course, DR-TB, drug resistance, Drug-resistant TB, e-course, e-learning, learning, lung health, program, TB, TB Union, The Union, Tuberculosis, Ukraine, Ukrainian
Continue Reading

Programmatic and Clinical Management of DR-TB Course

Programmatic and Clinical Management of DR-TB Course
Author(s): The Union
Year: 2021
Filed under: clinical, Course, DR-TB, drug resistance, Drug-resistant TB, e-course, e-learning, learning, lung health, program, TB, TB Union, The Union, Tuberculosis
Continue Reading

Drug-resistant tuberculosis treatment

Drug-resistant tuberculosis treatment
Author(s): WHO
Filed under: DR-TB, drug safety, drug safety monitoring, Drug-resistant TB, Guidelines, Management, management framework, performance indicators, TB, Treatment, treatment regimens, Tuberculosis, WHO, World Health Organization
Continue Reading

Active TB Drug-Safety Monitoring and Management: Manual for TB Medicines and Regimens

Active TB Drug-Safety Monitoring and Management: Manual for TB Medicines and Regimens
Author(s): National TB Programme Department of Public Health Ministry of Health and Sports The Republic of the Union of Myanmar
Year: 2017
Filed under: Burma, DR-TB, Drug-resistant TB, Guidance and Tools, mdr-tb, Monitoring, NTP, program management, XDR-TB
Continue Reading

Generic programmatic and clinical guide for the introduction of new drugs and shorter regimen for treatment of multi/extensively drug-resistant tuberculosis

Generic programmatic and clinical guide for the introduction of new drugs and shorter regimen for treatment of multi/extensively drug-resistant tuberculosis
Author(s): Challenge TB, KNCV Tuberculosis Foundation
Year: 2017
Filed under: DR-TB, Drug-resistant TB, Guidance and Tools, mdr-tb, multidrug-resistant TB, program management, Treatment, XDR-TB
Continue Reading

Drug-Resistant TB Self-Reporting of Drug-Related Adverse Events During Treatment

Drug-Resistant TB Self-Reporting of Drug-Related Adverse Events During Treatment
Author(s): Challenge TB, KNCV Tuberculosis Foundation
Year: 2019
Filed under: DR-TB, Drug-resistant TB, program management, TB patients, Treatment
Continue Reading

Guide for QTc monitoring and management of drug-resistant TB patients with QT-prolonging agents

Guide for QTc monitoring and management of drug-resistant TB patients with QT-prolonging agents
Author(s): Challenge TB, KNCV Tuberculosis Foundation
Year: 2018
Filed under: DR-TB, Drug-resistant TB, Guidance and Tools, Management, Monitoring, program management, TB patients
Continue Reading

Generic “New Drugs and the Shorter Treatment Regimen” Training Modules

Year: 2019
Filed under: Diagnostics, DR-TB, Drug-resistant TB, Guidance and Tools, NTP, TB care, Training, Treatment
Continue Reading

Posts navigation

Older Posts
  • Knowledge Hub
  • Data Hub
TB DIAH Project
University of North Carolina
123 West Franklin Street, Suite 330
Chapel Hill, North Carolina 27516 USA
About
Countries
Topics
Resource Library
News
TB DIAH Digest
Special Features
Assessments
TB Data Hub
Objectives

The TB DIAH project is part of USAID's performance-based measures to end TB—the Global Accelerator to End Tuberculosis. This TB DIAH website features a data hub, guidance, and tools to support the work of the global TB community. TB DIAH makes possible optimal analysis and use of TB data to inform national TB programs, policies, and USAID-supported interventions.

This information was produced with the support of the United States Agency for International Development (USAID) under the terms of the TB Data, Impact Assessment and Communications Hub (TB DIAH) Associate Award No. 7200AA18LA00007. TB DIAH is implemented by the University of North Carolina at Chapel Hill, in partnership with John Snow, Inc. Views expressed are not necessarily those of USAID or the United States government.